68Ga-bisphosphonates for the imaging of extraosseous calcification by positron emission tomography
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
68Ga-bisphosphonates for the imaging of extraosseous calcification by positron emission tomography ; volume:13 ; number:1 ; day:5 ; month:9 ; year:2023 ; pages:1-13 ; date:12.2023
Scientific reports ; 13, Heft 1 (5.9.2023), 1-13, 12.2023
- Urheber
-
Keeling, George P.
Baark, Friedrich
Katsamenis, Orestis L.
Xue, Jing
Blower, Philip J.
Bertazzo, Sergio
T. M. de Rosales, Rafael
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-023-41149-7
- URN
-
urn:nbn:de:101:1-2024020515025990353626
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:30 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Keeling, George P.
- Baark, Friedrich
- Katsamenis, Orestis L.
- Xue, Jing
- Blower, Philip J.
- Bertazzo, Sergio
- T. M. de Rosales, Rafael
- SpringerLink (Online service)
Ähnliche Objekte (12)
![[68Ga]Pentixafor–positron emission tomography/computed tomography detects chemokine receptor CXCR4 expression after ischemic stroke](/assets/placeholder/searchResultMediaUnknown.png)
[68Ga]Pentixafor–positron emission tomography/computed tomography detects chemokine receptor CXCR4 expression after ischemic stroke
68Ga-prostate-specific membrane antigen positron emission tomography/computed tomography: How much specific it is?
68Ga-DOTATATE positron emission tomography/computed tomography to detect the recurrence of phosphaturic mesenhcymal tumor-induced osteomalacia
Vascular uptake on 18F-sodium fluoride positron emission tomography: precursor of vascular calcification?
Positron emission tomography
Imaging of αvβ3 integrin expression in experimental myocardial ischemia with [68Ga]NODAGA-RGD positron emission tomography
Correlation between standardized uptake value of 68Ga-DOTA-NOC positron emission tomography/computed tomography and pathological classification of neuroendocrine tumors
Incidental detection of asymptomatic brain metastases on 18F-fluoride positron emission tomography/computed tomography and 68Ga DOTANOC positron emission tomography/computed tomography in a patient with concomitant breast carcinoma and a pancreatic neuroendocrine tumor
COVID-19 messenger ribonucleic acid vaccination and abnormal radiopharmaceutical uptake in the axilla visualized on 68Ga-DOTATATE positron-emission tomography/computed tomography
Positron Tomission Tomography : Clinical Practice
Additional information gained by positron emission tomography with 68Ga-DOTATOC for suspected unknown primary or recurrent neuroendocrine tumors
Quantitative accuracy of positron emission tomography/magnetic resonance and positron emission tomography/computed tomography for cervical cancer
[68Ga]Pentixafor–positron emission tomography/computed tomography detects chemokine receptor CXCR4 expression after ischemic stroke
68Ga-prostate-specific membrane antigen positron emission tomography/computed tomography: How much specific it is?
68Ga-DOTATATE positron emission tomography/computed tomography to detect the recurrence of phosphaturic mesenhcymal tumor-induced osteomalacia
Vascular uptake on 18F-sodium fluoride positron emission tomography: precursor of vascular calcification?
Positron emission tomography
Imaging of αvβ3 integrin expression in experimental myocardial ischemia with [68Ga]NODAGA-RGD positron emission tomography
Correlation between standardized uptake value of 68Ga-DOTA-NOC positron emission tomography/computed tomography and pathological classification of neuroendocrine tumors
Incidental detection of asymptomatic brain metastases on 18F-fluoride positron emission tomography/computed tomography and 68Ga DOTANOC positron emission tomography/computed tomography in a patient with concomitant breast carcinoma and a pancreatic neuroendocrine tumor
COVID-19 messenger ribonucleic acid vaccination and abnormal radiopharmaceutical uptake in the axilla visualized on 68Ga-DOTATATE positron-emission tomography/computed tomography
Positron Tomission Tomography : Clinical Practice
Additional information gained by positron emission tomography with 68Ga-DOTATOC for suspected unknown primary or recurrent neuroendocrine tumors
Quantitative accuracy of positron emission tomography/magnetic resonance and positron emission tomography/computed tomography for cervical cancer
[68Ga]Pentixafor–positron emission tomography/computed tomography detects chemokine receptor CXCR4 expression after ischemic stroke
68Ga-prostate-specific membrane antigen positron emission tomography/computed tomography: How much specific it is?
68Ga-DOTATATE positron emission tomography/computed tomography to detect the recurrence of phosphaturic mesenhcymal tumor-induced osteomalacia
Vascular uptake on 18F-sodium fluoride positron emission tomography: precursor of vascular calcification?
Positron emission tomography
Imaging of αvβ3 integrin expression in experimental myocardial ischemia with [68Ga]NODAGA-RGD positron emission tomography
Correlation between standardized uptake value of 68Ga-DOTA-NOC positron emission tomography/computed tomography and pathological classification of neuroendocrine tumors
Incidental detection of asymptomatic brain metastases on 18F-fluoride positron emission tomography/computed tomography and 68Ga DOTANOC positron emission tomography/computed tomography in a patient with concomitant breast carcinoma and a pancreatic neuroendocrine tumor
COVID-19 messenger ribonucleic acid vaccination and abnormal radiopharmaceutical uptake in the axilla visualized on 68Ga-DOTATATE positron-emission tomography/computed tomography
Positron Tomission Tomography : Clinical Practice
Additional information gained by positron emission tomography with 68Ga-DOTATOC for suspected unknown primary or recurrent neuroendocrine tumors